Cargando…

Rapid Identification and Drug Susceptibility Testing of Mycobacterium tuberculosis: Standard Operating Procedure for Non-Commercial Assays: Part 3: Colorimetric Redox Indicator Assay v1.3.12

The previous two standard operating procedures (SOPs) related to the culture and drug susceptibility testing (DST) of Mycobacterium tuberculosis with the microscopic observation drug susceptibility assay (Part 1) and nitrate reductase assay (Part 2). The present SOP is devoted to a third non-commerc...

Descripción completa

Detalles Bibliográficos
Autores principales: Singh, Sarman, Kumar, Parveen, Sharma, Shreya, Mumbowa, Francis, Martin, Anandi, Durier, Nicolas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3574496/
https://www.ncbi.nlm.nih.gov/pubmed/23440615
http://dx.doi.org/10.4103/0974-2727.105594
_version_ 1782259590639910912
author Singh, Sarman
Kumar, Parveen
Sharma, Shreya
Mumbowa, Francis
Martin, Anandi
Durier, Nicolas
author_facet Singh, Sarman
Kumar, Parveen
Sharma, Shreya
Mumbowa, Francis
Martin, Anandi
Durier, Nicolas
author_sort Singh, Sarman
collection PubMed
description The previous two standard operating procedures (SOPs) related to the culture and drug susceptibility testing (DST) of Mycobacterium tuberculosis with the microscopic observation drug susceptibility assay (Part 1) and nitrate reductase assay (Part 2). The present SOP is devoted to a third non-commercial culture and DST method known as colorimetric redox indicator assay (CRI). As its name indicates, the CRI detects the ability of the M. tuberculosis to reduce the colored oxidation-reduction indicator when added to a liquid culture of M. tuberculosis, after exposing the growth to different anti-mycobacterial drugs. The change in the color of the indicator denotes the proportionate number of viable Mycobacteria in the medium. The identification and DST results can be obtained in 7-8 days. This SOP document has been developed through the culture and DST subgroup of the STOP tuberculosis (TB) Partnership New Diagnostic Working Group. It is intended for laboratories that would want to use or already use this rapid non-commercial method for culture identification and DST of M. tuberculosis, notably in resource-constraint settings in Asia and Africa.
format Online
Article
Text
id pubmed-3574496
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-35744962013-02-22 Rapid Identification and Drug Susceptibility Testing of Mycobacterium tuberculosis: Standard Operating Procedure for Non-Commercial Assays: Part 3: Colorimetric Redox Indicator Assay v1.3.12 Singh, Sarman Kumar, Parveen Sharma, Shreya Mumbowa, Francis Martin, Anandi Durier, Nicolas J Lab Physicians How I do it? The previous two standard operating procedures (SOPs) related to the culture and drug susceptibility testing (DST) of Mycobacterium tuberculosis with the microscopic observation drug susceptibility assay (Part 1) and nitrate reductase assay (Part 2). The present SOP is devoted to a third non-commercial culture and DST method known as colorimetric redox indicator assay (CRI). As its name indicates, the CRI detects the ability of the M. tuberculosis to reduce the colored oxidation-reduction indicator when added to a liquid culture of M. tuberculosis, after exposing the growth to different anti-mycobacterial drugs. The change in the color of the indicator denotes the proportionate number of viable Mycobacteria in the medium. The identification and DST results can be obtained in 7-8 days. This SOP document has been developed through the culture and DST subgroup of the STOP tuberculosis (TB) Partnership New Diagnostic Working Group. It is intended for laboratories that would want to use or already use this rapid non-commercial method for culture identification and DST of M. tuberculosis, notably in resource-constraint settings in Asia and Africa. Medknow Publications & Media Pvt Ltd 2012 /pmc/articles/PMC3574496/ /pubmed/23440615 http://dx.doi.org/10.4103/0974-2727.105594 Text en Copyright: © Journal of Laboratory Physicians http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle How I do it?
Singh, Sarman
Kumar, Parveen
Sharma, Shreya
Mumbowa, Francis
Martin, Anandi
Durier, Nicolas
Rapid Identification and Drug Susceptibility Testing of Mycobacterium tuberculosis: Standard Operating Procedure for Non-Commercial Assays: Part 3: Colorimetric Redox Indicator Assay v1.3.12
title Rapid Identification and Drug Susceptibility Testing of Mycobacterium tuberculosis: Standard Operating Procedure for Non-Commercial Assays: Part 3: Colorimetric Redox Indicator Assay v1.3.12
title_full Rapid Identification and Drug Susceptibility Testing of Mycobacterium tuberculosis: Standard Operating Procedure for Non-Commercial Assays: Part 3: Colorimetric Redox Indicator Assay v1.3.12
title_fullStr Rapid Identification and Drug Susceptibility Testing of Mycobacterium tuberculosis: Standard Operating Procedure for Non-Commercial Assays: Part 3: Colorimetric Redox Indicator Assay v1.3.12
title_full_unstemmed Rapid Identification and Drug Susceptibility Testing of Mycobacterium tuberculosis: Standard Operating Procedure for Non-Commercial Assays: Part 3: Colorimetric Redox Indicator Assay v1.3.12
title_short Rapid Identification and Drug Susceptibility Testing of Mycobacterium tuberculosis: Standard Operating Procedure for Non-Commercial Assays: Part 3: Colorimetric Redox Indicator Assay v1.3.12
title_sort rapid identification and drug susceptibility testing of mycobacterium tuberculosis: standard operating procedure for non-commercial assays: part 3: colorimetric redox indicator assay v1.3.12
topic How I do it?
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3574496/
https://www.ncbi.nlm.nih.gov/pubmed/23440615
http://dx.doi.org/10.4103/0974-2727.105594
work_keys_str_mv AT singhsarman rapididentificationanddrugsusceptibilitytestingofmycobacteriumtuberculosisstandardoperatingprocedurefornoncommercialassayspart3colorimetricredoxindicatorassayv1312
AT kumarparveen rapididentificationanddrugsusceptibilitytestingofmycobacteriumtuberculosisstandardoperatingprocedurefornoncommercialassayspart3colorimetricredoxindicatorassayv1312
AT sharmashreya rapididentificationanddrugsusceptibilitytestingofmycobacteriumtuberculosisstandardoperatingprocedurefornoncommercialassayspart3colorimetricredoxindicatorassayv1312
AT mumbowafrancis rapididentificationanddrugsusceptibilitytestingofmycobacteriumtuberculosisstandardoperatingprocedurefornoncommercialassayspart3colorimetricredoxindicatorassayv1312
AT martinanandi rapididentificationanddrugsusceptibilitytestingofmycobacteriumtuberculosisstandardoperatingprocedurefornoncommercialassayspart3colorimetricredoxindicatorassayv1312
AT duriernicolas rapididentificationanddrugsusceptibilitytestingofmycobacteriumtuberculosisstandardoperatingprocedurefornoncommercialassayspart3colorimetricredoxindicatorassayv1312